Option chain shows key data for Novo Nordisk's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Novo Nordisk.

Novo Nordisk (OTC:NONOF) Stock, Option Chain

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Large Cap

News

Sector ETFs

Dividends

Small Cap

Markets

Trading Ideas

ETFs

DGRO

NONOF

Launched on 06/16/2006, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (ARCA:DNL) is a smart beta exchange traded fund offering broad exposure to the World ETFs category of the market.

Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF a Strong ETF Right Now?

Siegen,,North,Rhine,Westphalia,,,Germany,-,10,11,2023:

Biotech

Health Care

General

The greater weight loss in women did not result in significantly better improvements in heart failure symptoms.

Novo Nordisk&#39;s Wegovy Demonstrates Greater Weight Loss In Women With Heart Condition

weight loss ai

ZLDPF

As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the drug called petrelintide.

Move Aside Ozempic, WeGovy: Denmark&#39;s New Drug Just Showed Positive Results For Weightloss

NOVO NORDISK A/S B NEW by Novo-Nordisk A/S

Comments

Novo Nordisk

Novo Nordisk (NONOF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga